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INTRODUCTION
A nucleobase isomer such as isoguanine apparently
makes a non-standard base pair between 2'-deoxyisocy-
tidine and 2'-deoxyisoguanosine feasible when incorpo-
rated into oligomers. Some levels of functions in this
isomeric replacement are retained and in some instances
new functions are formed. The results reported by Swi-
tzer et al.1 have shown that various polymerases handle
this non-standard base pair, while Horn et al.2 reported
on the pairing in the absence of the enzyme. Here we re-
port on a subtle change in the molecular shape by re-
placing N3-nitrogen with the more liphophilic C3H-
group and C8H by N8-nitrogen. Though we do not pre-
vent the Watson-Crick pairing, the ring stacking might
be altered. The absence of N3-nitrogen in guanine intro-
duces an incorrectness that could disrupt the minor
groove spine of hydration, which means that it should
eliminate the presence of any ordered water molecules
or metal ions at this sequence position.3 Recently, it has
been demonstrated that in dA-dT sequences, the spine of
hydration should be considered an integral part of the
helix and that the possible metal ions binding in the mi-
nor groove is critical for the structural integrity of du-
plex DNA.4
In the light of these statements, our intention to de-
sign and carry out efficient synthesis of 8-aza-3-deaza-
isoguanosine 2 seemed attractive and significant espe-
cially when self-assembled properties of this molecule are
considered. Namely, guanosine (G) derivatives self-as-
sociate in the presence of metal ions to give hydro-
gen-bonded G-quartets5, while Cs+-selective ionophore,
properly protected isoG can also form a hydrogen-bond-
ed pentamer in the cation-templated process.6 These co-
valent assemblies selectively co-ordinate monovalent
and divalent cations to give extremely stable complexes.
Lack of one potential H-bond per molecule at N3-nitro-
gen donor may certainly weaken the H-bond pattern
though leaving sugar-base H-bonds transmitting stereo-
chemical information intact if the aggregates were
formed as in the isoG series.7 Therefore, considerable al-
ternations in binding affinity and selectivity are expected
when using this potential ionophore. This model can be
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further extended to its use in the search for structure-ac-
tivity relationships concerning G-rich oligodeoxynucleo-
tides (ODN) that may form G4-stabilized tetramers on mo-
novalent cations as templates or without.8 G4 or isoG4
containing structures may act as negative regulators of
telomerase elongation in vivo due to their ability to in-
hibit telomerase in vitro9 and it was demonstrated that
such ODNs are potent inhibitors of HIV-1 integrase.10
Seela et al.11 have recently established that the isoG quar-
tet is generally more stable than the G-quartet on the
first defined tetraplex species; however, structural chan-
ges of a heterocyclic base resulted in somewhat lower
stability for 7-deazaisoguanine quartet.11b
Despite remarkable interest in isoguanosine physical
and structural nature as well as in its 2-O-methylated
congener spongosine12 1, there have been no attempts to
perform the synthesis of 3-deaza analogues (Figure 1).
Strategically, the linear approach to 8-azapurine ring re-
building and achieving the synthesis of the correspond-
ing modifications relies on the availability of appropriate
5-member heterocyclic nucleoside intermediates suitable
for subsequent ring closure (Figure 2).13
RESULTS AND DISCUSSION
We have recently reported on a high-yield procedure for
the preparation of various 8-aza-3-deazaguanosine ana-
logues, which enabled us to select one of the two possi-
ble routes.13a One could follow the obvious work-out of
the parent ring system of 1-substituted-1,2,3-triazolo-
4,5-c pyridine by subsequent transformations. More ele-
gant and certainly much more efficient could be a di-
rected cyclization into the target compounds. Apparently,
the most convenient way to yield any 3-deazaguanosine
analogue by a ring closure, requires the key intermediate
4-ethoxycarbonyl or 5-cyanomethyl-1-(2,3,5-triacetyl--
-D-ribofuranosyl)imidazole and/or (1,2,3-triazole)-4-car-
boxamide (X = CH, N),14 namely a mononitrile-metho-
xycarbonylmethyl function.
The anticipated regioselective pathway requires an
aromatic nitrile in the place of a carboxylate function
that might reverse the course of the ring closure in
methanolic ammonia.15 However, it seems that no aro-
matic carboxamide precursor has ever been detected in
the work-out of a controlled selective ammonolysis of
5-methoxycarbonylmethyl-1--D-ribofuranosyl-1,2,3-tri-
azole-4-carboxylates.13 On the other hand, the diamide 3
(X = N) appeared in minor quantities in a reaction at 0 °C
and, by raising the temperature up to ambient condi-
tions, a 91 % yield of 3 (X = N) was obtained. 3 was
then readily converted to dinitrile 5 (X = N) in dry THF
at –10 °C to –2 °C in the presence of pyridine (Eq. 4)
with careful addition of 2.2 eq. of trifluoroacetic acid an-
hydride in THF (Scheme 1).
Intramolecular cyclizations between a cyanomethyl
group and an adjacent cyano group located on benzene,16
pyridine,17 or imidazole18 ring to form isoquinolines,
pyridocpyridines and imidazo4,5-cpyridines under acid-
catalyzed conditions have been reported. In addition, use
of hydrogen sulfide and triethylamine at room tempera-
ture took the same cyclization course.14a The same au-
thors described also the mild ring closure of 5 (X = CH)
to yield 2,6-diamino-3-deazaguanosine in methanolic
ammonia, which points to a different acting mechanism
under base-catalyzed conditions.
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Scheme 1. Synthesis of intermediates 4 and 5: a) 1.1 eq.
(CF3CO)2O, pyridine, THF, –10 °C; b) 2.2 eq. (CF3CO)2O, py-
ridine, THF, –10 °C.
A catalytic amount of sodium methoxide was added
to a stirred solution of 5 (X = N). After stirring (30 min)
and subsequent adjustment of pH (6.5–7), a new product
tentatively 6 was isolated from the solution (Scheme 2).
In the 1H NMR spectrum in DMSO-d6, a new aro-
matic proton appeared at  6.30, two exchangeable pro-
tons at  7.25, apparently belonging to the amino group,
and a sharp peak at  3.79, which was assigned to the
newly formed OCH3 substituent. Hitherto no NMR data
was available for comparison, yet the readily available
10 in our hands presumably implies an independent syn-
thetic approach in classical chemical transformations of
this interesting ring system, thus providing us with an
unambiguous structural proof (Scheme 3).
Acetylation of 10 afforded the suitable intermediate
11, which was further chlorinated with POCl3 in aceto-
nitrile in the presence of collidine and NEt4Cl in 70 %
yield. The leaving group in 12 turned to be, contrary to
that in the related ring system,19 quite a versatile precur-
sor. First, methanololysis with sodium methoxide in me-
thanol in a pressure bottle at 120 °C, adjusting the pH to
6.6–7.0, and final purification by column chromatogra-
phy has furnished 13 (Scheme 3). 1H NMR data revealed
distinct numbers from 6 1H NMR /ppm (DMSO-d6) 6.07
(H-3), 6.18 (NH2) and 4.00 (OCH3). MS (FAB), m/z =
298 (M+1), produced no notable change but a protonated
base (m/z = 166) in CID-Mike spectra of BH+ (or BH2+).
Careful hydrogenation of 12 afforded 14 (Scheme 5)

1H NMR /ppm (DMSO-d6) 8.87 (H-6), 6.79 (H-3,
J3,6 = 0.98Hz), which had not been previously reported.
3,6-Diamino compound 15 was obtained 1H NMR
/ppm (DMSO-d6) 5.72 (H-3), 7.62, 7.24 (4H, bs, NH2),
5.87 (1H, d, H-1') after heating 12 in liquid ammonia
for 16 hours. This structural correlation has definitely
proven that a novel synthetic method to 8-aza-3-
deazaspongosine analogues is available by the sodium
methoxide catalyst procedure. To make this statement
more general, several sodium alkoxides were employed.
The results are depicted in Scheme 2. The use of differ-
ent sodium alkoxides17 directed the cyclization of aroma-
tic (heterocyclic) nitriles with an adjacent cyanomethyl
group, e.g. the nitrogen of the aliphatic cyano group be-
coming the ring nitrogen of the pyridine moiety, in the
»reverse« way to the acid-catalyzed intramolecular cyc-
lizations.15a This is the first successful example in nu-
cleoside chemistry and the methodology is certainly of
high potential for the design of 2-alkoxy-8-aza-3-de-
aza-6-aminopurines aimed as potential coronary vasodi-
lators.20 The procedure corroborates some of the earlier
attempts21 relating to this type of ring closures. We can
conclude that catalytic amounts of the appropriate alk-
oxide are sufficient to generate the desired product.
However, more nucleophile (2, 3, 4 or 5 equivalents)
used in the reaction afforded a 20 % yield of the isome-
ric product 13. In that case, addition of excess methox-
ide to the aromatic nitrile might generate an imminium
ion, which then undergoes cyclization to the cyanome-
thyl group.21a To take advantage of alkoxides bearing re-
movable alkyl groups, 8-aza-3-deazaisoguanosine 2 was
obtained by standard deprotection of the benzylic group.
Finally, intermediate 3 was recognized as the antici-
pated precursor for providing the target nucleoside 2.
Our synthetic methodology was initially designed to
carry on the desired sugar configuration through subse-
quent steps.
The use of 2',3'-protected 6 allowed the application
of the Imbachs rule22 (  Me in C(CH3)2 = 17.5 Hz) for
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6 R = Me (69 %)
7 R = Et (26 %)
8 R = Pr (62 %)
9 R = Bn (42 %)
NH
Scheme 2. Ring closure reaction of dinitrile by sodium alkoxides:








































Scheme 3. Formation of isomeric 13 from 4: a) 1 M NEt3 in
80 % MeOH; b) Ac2O, pyridine, DMF; c) POCl3, collidine, NEt4Cl,



















Scheme 4. Removal of the benzyl group from 9: a) H2 / 5 %
Pd/C, 80 % EtOH.
the assignment of -configuration of 6 and 2, which was
readily obtained by catalytic hydrogenation of 9 in 80 %
ethanol and 5 % Pd/C. 1H NMR (DMSO-d6) /ppm
10.4 (1H, bs, NH), 7.29 (2H, bs, NH2), 5.88 (1H, d,
H-1'). In addition, in the attempted cleavage of the ether
bond in 6 in methanol, saturated with gaseous HCl at am-




1H and 13C spectra were obtained in DMSO-d6, and chemi-
cal shifts are reported on the -scale from TMS as an inter-
nal standard. Melting points were obtained on a Kofler mi-
cro stage and are uncorrected. IR spectra were obtained on
a Bio-Rad FTS 15/80 spectrometer and mass spectra on an
Avtospec Q spectrometer. All compounds gave satisfactory




azole-4-carboxylate13g (42.0 g, 127 mmol) was dissolved in
saturated NH3 (0 °C) in MeOH (700 ml), stirred at room
temperature for 24 h and the solvent evaporated to furnish
39.9 g (95 %) of red oil which was acetylated without fur-
ther purification.
IR (film) max/cm–1: 3464, 3131, 1599, 1285, 691, 540;
1H NMR (D2O) /ppm: 5.83 (1H, d, H-1', J1'2' = 2.7 Hz),
4.71 (1H, dd, H-2', J2'3' = 4.6 Hz), 4.28 (1H, m, H-3'), 3.97
(1H, m, H-4'), 3.94, 4.17 (2H, 2d, CH2CO), 3.55 (1H, dd,
H-5'a), 3.36 (1H, dd, H-5'b); MS (FAB) m/z: 302 (MH+).
The intermediate diamide (38.66 g, 128.3 mmol) was
dissolved in dry acetonitrile (500 ml), DMAP (1.18 g, 9.6
mmol) in pyridine (70.7 ml) was added and acetic anhy-
dride (43.7 ml, 462 mmol) was added dropwise under vig-
orous stirring. The reaction was carefully followed by TLC
(CH2Cl2 / CH3OH = 4 : 1). After o few hours of stirring, the
mixture was evaporated and the resulting residue was co-
evaporated with water (twice). The oily residue was then
dried, applied onto a silica gel column (250 g) and eluted
with a gradient solvent mixture of acetone in EtOAc (25–
40 %) to yield the white crystalline solid 3 (26.3 g, 48 %,
m.p. = 173–174 °C); IR (KBr) max/cm–1: 3449, 1751, 167,
1242, 1061, 617; 1H NMR (DMSO-d6) /ppm: 7.64, 7.36,
7.07, 6.64 (4H, 4 x br. s, 2 x NH2), 6.39 (1H, d, H-1', J1'2' =
2.5 Hz), 6.15 (1H, dd, H-2'), 5.79 (1H, dd, H-3'), 4.53 (1H,
m, H-4'), 4.41 (1H, m, H-5'a), 4.15 (1H, m, H-5'b), 3.98
(2H, CH2CO), 2.12, 2.08, 1.92 (3 x CH3CO); 13C NMR
(DMSO-d6) /ppm: 170.11, 169.65, 169.35 (3 x COCH3),
168.80, 162.57 (2 x CONH2), 139.22 (C-4), 135.73 (C-5),
88.10 (C-1'), 79.97 (C-4'), 73.61 (C-2'), 70.26 (C-3’), 62.55
(C-5'), 29.13 (CH2CO), 20.39, 20.36 (3 x COCH3); MS
(FAB) m/z: 428 (MH+, 62 %).
4-Cyano-5-cyanomethyl-1-(2,3,5-tri-O-acetyl--D-ribo-
furanosyl)-1,2,3-triazole (5)
Diamide 3 (2.7 g, 6.3 mmol, dried at 60 °C, 4 days over
P2O5) was dissolved in dry THF (40 ml, dried with LiAlH4
and distilled before use) and pyridine (2.13 ml, 26.5 mmol)
was added. The reaction mixture was cooled to –10 to 0 °C
and then trifluoroacetic anhydride (TFA, 1.9 ml, 13.3 mmol)
in THF (5 ml) was added dropwise. Additional stirring at 0
°C (30 min) and two hours at room temperature were ap-
plied before evaporation of the mixture to dryness and its
dissolving in dichloromethane (40 ml). Water (40 ml) was
added and the organic phase was separated and dried over
Na2SO4, and filtered to furnish dark oil, which was further
processed by column chromatography on silica gel (100 g)
with hexane / EtOAc = 2 : 3. Yellow crystals were sepa-
rated after evaporation (2.23 g, 90 %) and recrystallized
from EtOAc (m.p. = 98–99.5 °C); IR (KBr) max/cm–1:
2940, 2250, 1373, 1230, 1062, 921; MS (CI, NH3) m/z: 409
(MNH4+, 29 %); 1H NMR (DMSO-d6) /ppm: 1.85, 2.08,
2.15 (9H, 3s, CH3CO), 4.16, 4.69 (2H, 2d, CH2CN), 4.25
(1H, dd, H-5b'), 4.07(11H, m, H-5a'), 6.50 (1H, d, H-1'),
6.08 (1H, dd, H-2'), 5.60 (1H, m, 1H, H-3'); 13C NMR
/ppm: 169.70, 169.37, 169.13 (3 x COCH3), 136.46,
120.50 (2 x CN), 114.16 (C-4), 110.72 (C-5), 88.67 (C-1'),
80.52 (C-4'), 73.19 (C-2'), 69.77 (C-3'), 62.05 (C-5'), 20.0,
25.0, 20.14 (3 x COCH3), 12.70 (CH2CN);
Anal. Calcd. for C16H17N5O7: C 49.11, H 4.38, N
17.90 %; found: C 49.13, H 4.38, N 17.73 %.
General Procedure for 4-Amino-6-methoxy-1-(-D-ribo-
furanosyl)triazolo4,5-cpyridine
Dinitrile 5 (100 mg, 0.26 mmol) was dissolved in solution
of pulverized sodium in an appropriate alcohol (10 ml, 0.06
M) and stirred at room temperature for 30 min. Amberlit
IRC-50 (100 mg) was added and stirring was continued to
adjust pH to 6.5–7.0. The resin was filtered off, washed
twice with hot water (5ml) and the filtrate was evaporated.
The solid was collected and crystallized from isopropanol /
water = 4 : 1.
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Scheme 5. Synthesis of new derivatives 14 and 15: a) H2 / 5 %
Pd/C, EtOH; b) NH3 (l), 110 °C.
4-Amino-6-methoxy-1-(-D-ribofuranosyl)-1,2,3-triazolo-
4,5-cpyridine (6)
Yield: 69 % (white powder) m.p. = 190.5–191.5 °C; IR
(KBr) max/cm–1: 3456, 3365, 1640, 1614, 1497, 1251,
1212, 1125, 1043; 1H NMR (DMSO-d6) /ppm: 7.25 (2H,
s, NH2), 6.30 (1H, s, H-7), 6.03 (1H, d, H-1', J1'2' = 5.4 Hz),
4.62 (1H, m, H-2'), 4.20 (1H, m, H-3'), 3.98 (1H, m, H-4'),
3.79 (s, 3H, OMe), 3.59–3.49 (2H, m, H-5'a,b); 13C NMR
(DMSO-d6) /ppm: 163.5 (C-6), 150.9 (C-4), 141.4 (C-C-
7a), 120.9 (C-3a), 91.0 (C-1'), 86.3 (C-4'), 75.3 (C-7), 73.3
(C-2'), 71.0 (C-C-3'), 62.2 (C-5'), 54.9 (C-OMe); MS (EI)
m/z: 297 (M+, 33 %).
Anal. Calcd. for C11H15N5O5: C 44.46, H 4.97, N 23.35
%; found: C 44.50, H 4.92, N 23.35 %.
4-Amino-6-ethoxy-1-(-D-ribofuranosyl)-1,2,3-triazolo-
4,5-cpyridine (7)
Yield: 26 % (white powder); m.p. = 191–192.5 °C; IR (KBr)
max/cm–1: 3334, 3393, 3225, 1654, 1612,1595, 1209, 1128,
1051, 963; 1H NMR (DMSO-d6) /ppm: 7.22 (2H, s, NH2),
6.27 (1H, d, H-1', J1'2' = 5.4 Hz), 4.62 (1H, m, H-2'), 4.20
(3H, m, H-3' and OCH2CH3), 3.98 (1H, m, H-4'), 3.55 (2H,
m, H-5'a,b), 1.29 (3H, t, OCH2CH3, J = 7 Hz); 13C NMR
(DMSO-d6) /ppm: 162.2 (C-6), 150.5 (C-4), 140.7 (C-7a),
128.2 (C-3a), 90.5 (C-1'), 85.8 (C-4'), 75.1 (C-7), 72.7 (C-2'),
70.5 (C-3'), 61.9 (C-5'), 61.8 (CH3CH2O), 14.8 (CH3CH2O);
MS (FAB) m/z: 312 (MH+).
Anal. Calcd. for C12H17N5O5: C 46.30, H 5.50, N 22.50
%; found: C 46.33, H 5.95, N 22.30 %.
4-Amino-6-propoxy-1-(-D-ribofuranosyl)-1,2,3-triazolo-
4,5-cpyridine (8)
Yield: 62 % (white powder); m.p. = 184–185.5 °C; IR
max/cm–1: 3405, 3332, 3222, 1653, 1609, 1496, 1204,
1047; 1H NMR (DMSO-d6) /ppm: 7.21 (2H, s, NH2), 6.28
(1H, s, H-7), 6.05 (1H, d, H-1', J1'2' = 5.6 Hz), 4.64 (1H, m,
H-2'), 4.22 (1H, m, H-3'), 4.11 (2H, t, OCH2CH2CH3, J =
6.6 Hz), 3.99 (1H, m, H-4'), 3.56 (2H, m, H-5'a,b), 1.70 (2H,
m, OCH2CH2CH3), 0.95 (3H, t, OCH2CH2CH3, J = 7.3 Hz);
13C NMR (DMSO-d6) /ppm: 162.4 (C-6), 150.5 (C-4),
140.7 (C-7a), 128.2 (C-3a), 90.5 (C-1'), 85.8 (C-4'), 75.0
(C-7), 72.7 (C-2'), 70.5 (C-3'), 68.8 (OCH2CH2CH3), 61.8
(OCH2CH2CH3), 10.5 (OCH2CH2CH3); MS (EI) m/z: 325




Yield: 42 % (white powder); m.p. = 166–167.5 °C; IR
max/cm–1: 3476, 3340, 1643, 1611, 1492, 1436, 1197,
1100, 1054; 1H NMR (DMSO-d6) /ppm: 7.40 (5H, m, Ph),
7.31 (2H, s, NH2), 6.36 (1H, s, H-7), 6.05 (1H, d, H-1', J1'2'
= 6.6 Hz), 5.30 (2H, s, CH2Ph), 4.63 (1H, m, H-2'), 4.21
(1H, m, H-3'), 3.99 (1H, m, H-4'), 3.56 (2H, m, H-5'a,b);
13C NMR (DMSO-d6) /ppm: 161.8 (C-6), 150.5 (C-4),
140.8 (C-3a), 137.6 (C-7a), 128.4, 128.3, 128.0, 127.9,
127.3 (Ph), 90.5 (C-1'), 85.7 (C-4'), 75.6 (C-7), 72.7 (C-2'),
70.5 (C-3'), 67.5 (CH2Ph), 61.8 (C-5'); MS (EI) m/z: 373




A solution of 6-amino-1-(-D-ribofuranosyl)triazolo4,5-c-
pyridine-4(5H)-on, (1.34 g, 4.7 mmol; dried for 2 days over
P2O5 at 110 °C) in dried DMF (40 ml) was treated with py-
ridine (1.5 ml, 18.8 mmol) and acetic anhydride (2.6 ml,
18.8 mmol), which was slowly added under vigorous stir-
ring. The resulting mixture was then heated under reflux for
5 hours and evaporated. The sticky residue was dissolved in
isopropanol (25 ml) and refluxed for 15 min, and allowed
to cool (–20 °C). The solid was separated overnight to yield
11 (1.32 g, 78 %, m.p. = 217–220 °C). IR (KBr) max/cm–1:
3464, 3343, 3185, 1747, 1683, 1636, 1432, 1373, 1235,
1044, 788; 1H NMR (CDCl3) /ppm: 10.76 (1H, br.s, NH),
6.31 (1H, d, H-1'), 6.19 (2H, br.s, NH2), 5.95 (1H, dd, H-2',
J1'2' = 2.7 Hz), 5.61 (1H, dd, H-3'), 5.49 (1H, s, H-7), 4.45
(1H, m, H-4'), 4.34 (1H, m, 1H, H-5'a), 4.05 (1H, dd,
H-5'b), 2.12, 2.11, 1.91 (3 x s, 9H, 3 x Ac); 13C NMR
(DMSO-d6) /ppm: 170.0, 169.6, 169.5 (CH3CO), 155.3
(C-4), 151.1 (C-6), 142.8 (C-7a), 120.9 (C-3a), 87.1 (C-1'),
79.5 (C-4'), 72.8 (C-2'), 70.2 (C-3'), 66.8 (C-7), 62.4 (C-5'),
20.4, 20.3, 20.3 (CH3CO); MS (FAB) m/z: 410 (MH+, 31
%).
Anal. Calcd. for C16H19N5O8: C 46.95, H 4.68, N
17.11 %; found: C 47.35, H 4.63, N 16.89 %.
6-Amino-4-chloro-1-(2,3,5-tri-O-acetyl--D-ribofurano-
syl)-1,2,3-triazolo4,5-cpyridine (12)
MeCN (50 ml, dried over CaH2) was directly distilled into
a carefully dried three-neck flask loaded with 11 (1.5 g, 6
mmol, dried at 120 °C over P2O5) and NEt4Cl (1.4 g, dried
at 80 °C) and equipped with a reflux condenser. Collidine
(0.465 ml, 3.5 mmol) was then added and freshly distilled
POCl3 (1.9 ml, 21 mmol) was added dropwise. The reac-
tion mixture was heated at 70 °C for 12 min, the solvents
were removed at a temperature below 45 °C and the yellow
residue was treated with ice (approx. 30 g). After adjusting
pH to 6–7 with sat. NaHCO3 at 0–5 °C, the water phase
was extracted with hexane (3 x 10 ml) and dichloromethane
(2 x 10 ml). The organic phase was dried over Na2SO4, the
solvents were removed, and the oily residue was then ap-
plied onto a preparative column (silica gel, 20 g). The
foamy product 12 (1.11 g, 70 %, m.p. = 53–55 °C) was ob-
tained after elution with benzene / EtOAc = 2 : 1.
IR (KBr) max/cm–1: 3469, 3370, 1741, 1623, 1478,
1374, 1243, 1048, 989, 600; 1H NMR (CDCl3) /ppm: 6.37
(1H, s, H-7), 6.22 (1H, d, H-1', J1'2' = 3.9 Hz), 6.12 (1H, dd,
H-2'), 5.72 (1H, m, H-3'), 5.02 (2H, br.s, NH2), 4.50 (1H,
m, H-4'), 4.42 (1H, dd, H-5'a), 4.20 (1H, dd, H-5'b), 2.15,
2.13, 2.02 (9H, s, CH3CO); 13C NMR (CDCl3) /ppm:
170.54, 169.59, 169.46 (CH3CO), 156.58 (C-4), 141.11
(C-6), 138.70 (C-7a), 128.29 (C-3a), 88.21 (C-1'), 82.23
(C-7), 80.87 (C-5'), 73.28 (C-2'), 70.74 (C-3'), 62.63 (C-4'),
20.54, 20.45, 20.38 (CH3CO); MS (EI) m/z: 427 (M+, 41
SYNTHESIS OF 8-AZA-3-DEAZAISOGUANOSINE 157
Croat. Chem. Acta 77 (1–2) 153–160 (2004)
%); HRMS Calcd. for C16H18N5O7Cl: 427.090270; found:
427.089476.
Anal. Calcd. for C16H18N5O7Cl: C 44.99, H 4.24, N
16.27 %; found: C 45.39, H 4.20, N 15.87 %.
Deprotection of 12
A solution of 12 (150 mg, 0.35 mmol) in NaOMe in MeOH
(10 ml, 40 mmol sol.) was stirred at room temperature for 3
h. Amberlit-IRC50 (50 mg) was added to adjust pH to
6.5–7. The resin was filtered off, washed with hot water (2
x 20 ml) and the combined filtrates were evaporated. The
resulting residue was crystallized from propanol to afford a
white solid (98 mg, 93 %, m.p. = 155 °C (dec.)).
IR (KBr) max/cm–1: 3469, 3364, 3298, 1634, 1490, 1280,
1147, 1104, 1036, 942, 802, 609; 1H NMR (DMSO-d6)
/ppm: 6.63 (2H, br.s, NH2), 5.18 (1H, s, H-7), 6.04 (1H, d,
H-1', J1'2' = 5.1 Hz), 4.68 (1H, m, H-2'), 4.22 (1H, m, H-3'),
4.00 (1H, m, H-4'), 3.56 (2H, m, H-5'ab); 13C NMR
(DMSO-d6) /ppm: 157.9 (C-4), 141.0 (C-6), 140.2 (C-7a),
134.7 (C-3a), 90.6 (C-1'), 85.9 (C-5'), 81.8 (C-7), 72.8
(C-2'), 70.5 (C-3'), 61.7 (C-4'); MS (EI) m/z: 301 (M+,




A solution of 12 (150 mg, 0.47 mmol) in MeOH (4 ml) and
NaOMe (89 mg, 2.33 mmol) was heated at 120 °C in a
sealed pressure tube for 25 h, cooled and neutralized with
Amberlit-12-C-50 (80 mg; pH = 6.5–7). The resin was fil-
tered off and washed with hot water (2 x 10 ml). The fil-
trate was evaporated and the residue was purified by col-
umn chromatography (silica gel, 40 g) with CHCl3 / MeOH
= 10 : 1 mixture to yield 14 as yellow crystals (60 mg, 43
%, m.p.= 178–182 °C); IR (KBr) max/cm–1: 3411, 3335,
3281, 1627, 1498, 1389, 1279, 1197, 1111, 1059; 1H NMR
(DMSO-d6) /ppm: 6.18 (2H, br.s, NH2), 6.07 (1H, s, H-7),
5.93 (1H, d, H-1'), 4.64 (1H, dd, H-2', J1'2' = 4.6 Hz, J2'3' =
8.4 Hz), 4.18 (1H, m, H-3'), 4.00 (3H, s, OMe), 3.97 (1H,
m, H-4'), 3.57 (1H, m, H-5'a), 3.47 (1H, dd, H-5'b, J1 =
11.7 Hz, J2 = 5.2 Hz); 13C NMR (DMSO-d6) /ppm: 157.0
(C-4), 154.5 (C-6), 142.1 (C-7a), 126.6 (C-3a), 90.1 (C-1'),
85.7 (C-4'), 75.7 (C-7), 72.6 (C-2'), 70.6 (C-3'), 61.9 (C-5'),
53.3 (OMe); MS (FAB) m/z: 298 (MH+, 22 %); HRMS
Calcd. for C11H15N5O5: 298.115544; found: 298.115144.
4-Amino-6-methoxy-1-(2,3-O-isopropylidene--D-ribo-
furanosyl)triazolo4,5-cpyridine
To a solution of 13 (50 mg, 0.17 mmol) in dry acetone, tri-
ethylortoformate (110 l, 0.16 mmol) and p-toluenesulfonic
acid monohydrate (30 mg, 0.03 mmol) were added and the
resulting mixture was stirred under N2 at room temperature
for 5h. The solution was evaporated and the residue was
purified by column chromatography (silica gel, 7 g, EtOAc).
Recrystallization from water afforded a white crystalline
solid (40 mg, 70 %, m.p. = 154–155 °C); IR (KBr)
max/cm–1: 3430, 3334, 3223, 1644, 1607, 1491, 1290,
1219, 1162, 1027, 972, 866, 747; 1H NMR (DMSO-d6)
/ppm: 7.32 (2H, s, NH2), 6.42 (1H, d, H-1', J1'2' = 2.0 Hz),
6.28 (1H, s, H-7), 5.59 (1H, dd, H-2'), 5.02 (1H, m, H-3'),
4.20 (1H, m, H-4'), 3.82 (3H, s, OCH3), 3.28 (2H, m,
H-5'ab), 1.55, 1.37 (6H, s, (CH3)2C); 13C NMR (DMSO-d6)
/ppm: 162.95 (C-4), 150.54 (C-6), 141.19 (C-7a), 128.12
(C-3a), 112.90 CH3CCH3), 90.75 (C-1'), 87.62 (C-4'),
83.00 (C-2'), 81.70 (C-3'), 74.75 (C-7), 61.05 (C-5'), 54.04
(OCH3), 26.75, 24.98 (CH3CCH3); MS (EI) m/z: 337 (M+,
10 %); HRMS Calcd for C14H19N5O5: 337.139410; found:
337.138619.
Anal. Calcd. for C14H19N5O5: C 49.83, H 5.68, N
20.47 %; found: C 49.71, H 5.60, N 20.47 %.
Depurination of 13: 4-Amino-6-methoxy-1H-1,2,3-tri-
azolo4,5-cpyridine.
Compound 6 (100 mg, 0.34 mmol) was dissolved in MeOH
(20 ml) saturated with gaseous HCl at 0 °C, and the solu-
tion was stirred in a pressure flask at room temperature
overnight. The resulting mixture was evaporated and the
residue was recrystallized from MeOH. Basic heterocycle
4-amino-6-methoxy-1H-1,2,3-triazolo4,5-cpyridine was iso-
lated in 29 % yield.
1H NMR (D2O) /ppm: 6.22 (1H, s, H-7), 3.82 (3H, s,
OCH3); 13C NMR (D2O) /ppm: 155.4 (C-3a), 147.7 (C-7a),
101.4 (C-7), 98.5 (C-4), 73.8 (C-6), 57.2 (OCH3); MS (EI)




A suspension of 12 (150 mg, 0.35 mmol) in liquid NH3 (30
ml) was heated at 120 °C in an autoclave reactor for 16 h.
After cooling, NH3 was allowed to evaporate and the resi-
due was redissolved in MeOH and neutralized (pH = 7), then
purified on a preparative silica gel plate (MeOH/EtOAc =
1:4) and recrystallized from EtOH to furnish a crystalline
solid (43 mg, 43 %, m.p. = 214–217 °C); 1H NMR
(DMSO-d6) /ppm: 7.62 (2H, br.s, NH2), 7.24 (2H, br.s,
NH2), 5.87 (1H, d, H-1'), 5.72 (1H, s, H-7), 4.64 (1H, m,
H-2'), 4.20 (1H, m, H-3'), 2.19 (1H, m, H-4'), 3.63 (1H, m,
H-5'a), 3.47 (1H, m, H-5'b); 13C NMR (DMSO-d6) /ppm:
160.9 (C-4), 151.1 (C-6), 141.0 (C-7a), 126.5 (C-3a), 90.1
(C-1'), 85.6 (C-4'), 72.6 (C-7), 72.1 (C-2'), 70.7 (C-3'), 62.2
(C-5'); MS (EI) m/z: 282 (M+, 4 %); HRMS Calcd. for
C10H14N6O4: 282.108650; found: 282.107653.
6-Amino-1-(-D-ribofuranosyl)-1,2,3-triazolo4,5-c-
pyridine (14)
To a suspension of 12 (150 mg, 0.35 mmol) in water (30
ml), NaOH (55 mg, 1.36 mmol) was added and the mixture
was stirred at room temperature until compound 12 was
completely dissolved. A catalyst (50 mg, 5 % Pd/C) was
then added and the resulting mixture was hydrogenated in a
Parr hydrogenator at room temperature and 3.3 bar for 40
min. Amberlit-IRC-50 was added to the suspension, which
was stirred overnight, filtered, the cake was washed twice
with hot water (10 ml) and the filtrate was evaporated. The
residue was dissolved in MeOH and purified on preparative
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chromatographic plate in MeOH / EtOAc = 1:4 to furnish
slightly yellow crystals (86 mg, 92 %, m.p. = 182–186 °C);
IR(KBr) max/cm–1: 3344, 3257, 1631, 1564, 1414, 1254,
1114, 623; 1H NMR (DMSO-d6) /ppm: 8.87 (1H, d, H-4,
J47 = 0.98 Hz), 6.79 (1H, d, H-7, J67 = 0.98 Hz), 6.31 (2H,
br.s, NH2), 6.28 (1H, d, H-1', J1'2' = 4.2 Hz), 5.01 (1H, m,
H-2'), 4.59 (1H, m, H-3'), 4.27 (1H, m, H-4'), 3.85 (1H, m,
H-5'a), 3.73 (1H, m, H-5'b); 13C NMR (DMSO-d6) /ppm:
158.4 (C-6), 142.5 (C-4), 138.9 (C-C-7a), 138.3 (C-3a),
90.1 (C-1'), 85.8 (C-4'), 82.2 (C-C-7), 72.6 (C-2'), 70.6
(C-3'), 61.8 (C-5'); MS (EI) m/z: 267 (M+, 3 %); HRMS
Calcd. for C10H13N5O4: 267.097750; found: 267.096754.
4-Amino-1-(-D-ribofuranosyl)-1,2,3-triazolo4,5-c-
pyridine-6(5H)-on (2)
To a solution of 9 (50 mg, 0.13 mmol) in 80 % EtOH (50
ml), Pd/C (30 mg, 5 %) was added and the suspension was
hydrogenated in a Parr hydrogenator at room temperature
and 3.3 bar for 3 h. The catalyst was filtered off and
washed twice with hot EtOH (10 ml). Next, the filtrate was
evaporated and the residue was recrystallized from MeOH /
EtOAc = 2:3 to yield 2 (10 mg, 30 %, m.p. = 218 –222 °C);
IR (KBr) max/cm–1: 3389, 3188, 2924, 2768, 1695, 1619,
1487, 1408, 1260, 1209, 1112, 1052, 771, 563; 1H NMR
(DMSO-d6) /ppm: 10.4 (1H, br.s, NH), 7.29 (2H, br.s,
NH2), 5.88 (1H, d, H-1', J1'2' = 5.4 Hz), 5.68 (1H, s, H-3),
5.47 (1H, br.s, 2'-OH), 5.23 (1H, br.s, 3'-OH), 4.87 (1H,
br.s, 5'-OH), 4.61 (1H, m, H-2'), 4.18 (1H, m, H-3'), 3.94
(1H, m, H-4'), 3.52 (2H, m, H-5'ab); 13C NMR (DMSO-d6)
/ppm: 161.6 (C-6), 149.3 (C-4), 142.2 (C-3a), 115.6
(C-7a), 89.9 (C-1'), 85.5 (C-4'), 73.4 (C-7), 72.4 (C-2'),
70.4 (C-3'), 61.8 (C-5'); MS (EI) m/z: 283 (M+, 13 %); MS
(FAB) m/z: 284 (M++1); HRMS Calcd. for C10H13N5O5:
283.091669; found: 283.091890.
CONCLUSIONS
In conclusion, 5 can be used in a novel base-catalyzed
ring closure for the synthesis of a variety of 2-alkoxy-
-8-aza-3-deazaadenosines, namely new 8-azaspongosine
analogues.12 The proper choice of alkoxides (e.g., so-
dium benzylate) enables easy deprotection of 9 to the
target 8-aza-3-deazaisoguanosine 2. Further studies of
its self-assembling properties are in progress.
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SA@ETAK
Priprava 8-aza-3-deazaizoguanozina s novim zatvaranjem prstena pomo}u natrijeva alkoksida
Marjan Je{elnik, Suzana Jak{a i Jo`e Kobe
U ~lanku je opisano izravno zatvaranje prstena 4-ciano-5-cianometil-1-(-D-ribofuranizil)-1,2,3-triazolo-
4,5-cpiridina u bazi~nim uvjetima u 4-amino-5-alkoksi-1-(-D-ribofuranizil)-1,2,3-triazolo4,5-cpiridin, koji
se lako transformira u 8-aza-3-deazaizoguanozin.
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